financetom
Business
financetom
/
Business
/
Linde Q2 Adjusted Earnings, Sales Rise, Full-Year EPS Outlook Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Linde Q2 Adjusted Earnings, Sales Rise, Full-Year EPS Outlook Revised
Aug 1, 2025 3:35 AM

06:05 AM EDT, 08/01/2025 (MT Newswires) -- Linde ( LIN ) reported Q2 adjusted earnings Friday of $4.09 per diluted share, up from $3.85 a year earlier.

Analysts polled by FactSet expected $4.03.

Sales for the quarter ended June 30 were $8.5 billion, up from $8.27 billion a year earlier.

Analysts surveyed by FactSet expected $8.36 billion.

For 2025, Linde ( LIN ) now projects adjusted EPS between $16.30 and $16.50, compared with a prior guidance range of $16.20 to $16.50. Analysts polled by FactSet expect $16.41.

For Q3, the company projects adjusted EPS at $4.10 to $4.20. Analysts surveyed by FactSet expect $4.20.

Linde ( LIN ) shares were up 1.1% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BIO-key Gets $500,000 in New Orders for Biometric Authentication -- Shares Soar
BIO-key Gets $500,000 in New Orders for Biometric Authentication -- Shares Soar
Sep 11, 2024
02:00 PM EDT, 09/10/2024 (MT Newswires) -- BIO-key International ( BKYI ) said Tuesday it has received more than $500,000 in new orders from a government defense ministry for biometric user authentication. The ministry placed the order under a three-year purchasing deal, the company said. BIO-key shares soared 92% in recent trading. Price: 2.00, Change: +0.96, Percent Change: +92.12 ...
Market Chatter: AstraZeneca 'Working Very Closely' With Chinese Authorities on Probe, CEO Tells Bloomberg
Market Chatter: AstraZeneca 'Working Very Closely' With Chinese Authorities on Probe, CEO Tells Bloomberg
Sep 11, 2024
02:09 PM EDT, 09/10/2024 (MT Newswires) -- AstraZeneca ( AZN ) is working very closely with Chinese authorities probing the company's employees for possible violations, Chief Executive Pascal Soriot told Bloomberg, according to a Tuesday report. Authorities are investigating whether the company's collection of patient data violated data privacy laws, according to the report. They are also probing the involvement...
Bank of America CEO says Buffett has been a great backer, hasn't asked about stock sales
Bank of America CEO says Buffett has been a great backer, hasn't asked about stock sales
Sep 11, 2024
TORONTO (Reuters) - Bank of America ( BAC ) CEO Brian Moynihan said on Tuesday Warren Buffett has been a great investor in the company, but he has not asked the legendary investor about recent moves to reduce his stake in the lender. He has been a great investor for our company, stabilized our company, Moynihan said about Buffett during...
FTC may probe potential Seven & i, Couche-Tard deal, sources say
FTC may probe potential Seven & i, Couche-Tard deal, sources say
Sep 11, 2024
NEW YORK, Sept 10 (Reuters) - U.S. antitrust regulators have told Seven & i ( SVNDF ) it may probe a potential deal with Canada's Alimentation Couche-Tard ( ANCTF ), two sources familiar with the matter said, in an early sign that a merger could face regulatory scrutiny. The Federal Trade Commission sent Seven & i ( SVNDF ) a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved